scholarly article | Q13442814 |
P356 | DOI | 10.1016/S0002-9343(88)80086-X |
P698 | PubMed publication ID | 3052050 |
P2093 | author name string | Shaw S | |
Weidmann P | |||
Blumberg A | |||
Gnädinger M | |||
P2860 | cites work | Changes in plasma potassium concentration during acute acid-base disturbances | Q34276267 |
Blood levels and renal effects of atrial natriuretic peptide in normal man. | Q34526123 | ||
The effect in humans of extracellular pH change on the relationship between serum potassium concentration and intracellular potassium | Q35560432 | ||
Influence of basal insulin and glucagon secretion on potassium and sodium metabolism. Studies with somatostatin in normal dogs and in normal and diabetic human beings | Q37051149 | ||
Correction of hyperkalemia by bicarbonate despite constant blood pH | Q39182953 | ||
Control of aldosterone responsiveness in terminal renal failure | Q39933686 | ||
Internal Potassium Balance and the Control of the Plasma Potassium Concentration | Q40126106 | ||
The effect of acute respiratory acidosis on the internal equilibrium of potassium | Q40994082 | ||
Distribution of sodium bicarbonate infused into nephrectomized dogs | Q40994419 | ||
Disposition of intravenous potassium in anuric man: A kinetic analysis | Q41694497 | ||
THE POTASSIUM EQUILIBRIUM IN MUSCLE. | Q42839991 | ||
Immunoassay of insulin with insulin-antibody precipitate | Q42961363 | ||
Hypertonic expansion: acid-base and electrolyte changes | Q44401174 | ||
Effect of potassium removal during hemodialysis on the plasma potassium concentration. | Q52746521 | ||
Acute hyperkalemia induced by hyperglycemia: hormonal mechanisms | Q67478564 | ||
Hemodialysate composition and intradialytic metabolic, acid-base and potassium changes | Q68183284 | ||
The renin system: Variations in man measured by radioimmunoassay or bioassay | Q68687899 | ||
Potassium-lowering effect of albuterol for hyperkalemia in renal failure | Q69777866 | ||
Impairment of beta 2-adrenoceptor-stimulated potassium uptake in end-stage renal disease | Q69807567 | ||
Beta adrenergic control of extrarenal potassium disposal. A beta-2 mediated phenomenon | Q69882514 | ||
Plasma levels and cardiovascular, endocrine, and excretory effects of atrial natriuretic peptide during different sodium intakes in man | Q69991134 | ||
Mechanisms of autonomic nervous system dysfunction in uremia | Q70183489 | ||
Hypokalemia from Beta2-Receptor Stimulation by Epinephrine | Q70209555 | ||
Impairment of extrarenal potassium disposal by alpha-adrenergic stimulation | Q70220009 | ||
Acetate metabolism and bicarbonate generation during hemodialysis: 10 years of observation | Q70345660 | ||
Epinephrine and potassium homeostasis | Q70979738 | ||
Blunted kaliuresis after an acute potassium load in patients with chronic renal failure | Q71172961 | ||
Alpha- and Beta-Adrenoceptor Changes in Patients on Maintenance Hemodialysis1 | Q72410928 | ||
Adrenergic Modulation of Extrarenal Potassium Disposal | Q72418435 | ||
Effect of insulinopenia and adrenal hormone deficiency on acute potassium tolerance | Q72428230 | ||
Varying role of extracellular electrolytes in metabolic acidosis and alkalosis | Q78459493 | ||
The use of 2-amino-2-hydroxymethyl-1, 3-propanediol in the management of renal acidosis | Q79012353 | ||
Norepinephrine-related mechanism in hypertension accompanying renal failure | Q93674521 | ||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 507-512 | |
P577 | publication date | 1988-10-01 | |
P1433 | published in | American Journal of Medicine | Q2842959 |
P1476 | title | Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure | |
P478 | volume | 85 |
Q48246502 | A Comparison of Insulin Doses for the Treatment of Hyperkalemia in Patients with Renal Insufficiency. |
Q38087426 | A clinical review of pathophysiology, diagnosis, and treatment of uroabdomen in the dog and cat. |
Q37912079 | A patient with hyperkalemia and metabolic acidosis |
Q35921862 | A phase 2 study on the treatment of hyperkalemia in patients with chronic kidney disease suggests that the selective potassium trap, ZS-9, is safe and efficient |
Q37786565 | Abnormalities of serum potassium concentration in dialysis-associated hyperglycemia and their correction with insulin: review of published reports. |
Q54284569 | Adrenergic modulation of extrarenal potassium disposal in men with end-stage renal disease |
Q68642509 | Albuterol and insulin for treatment of hyperkalemia in hemodialysis patients |
Q38742591 | Clinical features and management of poisoning due to potassium chloride |
Q35887583 | Critical care in uraemic children |
Q64100065 | Current treatment and unmet needs of hyperkalaemia in the emergency department |
Q35612279 | Diagnosis and management of electrolyte emergencies |
Q42260651 | Effect of Intravenous Small-Volume Hypertonic Sodium Bicarbonate, Sodium Chloride, and Glucose Solutions in Decreasing Plasma Potassium Concentration in Hyperkalemic Neonatal Calves with Diarrhea. |
Q71614003 | Effect of bicarbonate administration on plasma potassium in dialysis patients: interactions with insulin and albuterol |
Q51602538 | Effect of insulin-plus-glucose infusion with or without epinephrine on fasting hyperkalemia. |
Q44283149 | Effect of prolonged bicarbonate administration on plasma potassium in terminal renal failure |
Q71492950 | Effective treatment of acute hyperkalaemia in childhood by short-term infusion of salbutamol |
Q42739348 | Effects of alkalinization and rehydration on plasma potassium concentrations in neonatal calves with diarrhea |
Q35595495 | Effects of pH on potassium: new explanations for old observations |
Q24243982 | Emergency interventions for hyperkalaemia |
Q37021698 | Emergency management and commonly encountered outpatient scenarios in patients with hyperkalemia |
Q37413170 | Extrarenal potassium tolerance in chronic renal failure: implications for the treatment of acute hyperkalemia |
Q34348041 | Fluid and electrolyte abnormalities |
Q34598337 | Fluid and electrolyte disturbances in critically ill patients |
Q51674878 | Hyperkalaemia: a complication of warm heart surgery. |
Q34419220 | Hyperkalemia in dialysis patients |
Q34753785 | Hyperkalemia in the elderly: drugs exacerbate impaired potassium homeostasis |
Q24541435 | Hyperkalemia revisited |
Q34448823 | Hyperkalemia: a review |
Q39519287 | Hypertensive crisis precipitated by insulin-induced hypoglycemia with end-stage renal failure. |
Q51374845 | Hypertonic saline treatment of severe hyperkalemia in nonnephrectomized dogs. |
Q34103327 | Hypokalaemia and hyperkalaemia |
Q72780112 | Hypokalemic effects of intravenous infusion or nebulization of salbutamol in patients with chronic renal failure: comparative study |
Q35645706 | Insulin effect on bupivacaine-induced cardiotoxicity in rabbits |
Q42181445 | Insulin for the treatment of hyperkalemia: a double-edged sword? |
Q86379635 | Letter to the Editor |
Q86413918 | Letter to the Editor |
Q44514392 | Levalbuterol is as effective as racemic albuterol in lowering serum potassium |
Q38052452 | Management of hyperkalaemia consequent to mineralocorticoid-receptor antagonist therapy |
Q33160624 | Mild hyperkalemia and low eGFR a tedious recipe for cardiac disaster in the elderly: an unusual reversible cause of syncope and heart block |
Q64915014 | New options for the management of chronic hyperkalemia. |
Q35556291 | Noninvasive potassium determination using a mathematically processed ECG: proof of concept for a novel "blood-less, blood test" |
Q40740152 | Normal renin-aldosterone-insulin and potassium interrelationship in FMF patients and amyloid nephropathy |
Q36009244 | Optimal Dose and Method of Administration of Intravenous Insulin in the Management of Emergency Hyperkalemia: A Systematic Review |
Q38783092 | Pharmacodynamics and pharmacokinetics of sodium zirconium cyclosilicate [ZS-9] in the treatment of hyperkalemia |
Q24186355 | Pharmacological interventions for the acute management of hyperkalaemia in adults |
Q38145333 | Potassium balance in dialysis patients |
Q40458805 | Potassium homeostasis and its disturbances in children |
Q46979818 | Preferred treatment of hyperkalemia |
Q40675355 | Prolonged asystolic hyperkalemic cardiac arrest with no neurologic sequelae |
Q40344401 | Runner's new diet, his collapse, and his ECG: when a rapid ECG diagnosis can save the day |
Q46726008 | The efficiency of potassium removal during bicarbonate hemodialysis |
Q45248510 | The faster potassium-lowering effect of high dialysate bicarbonate concentrations in chronic haemodialysis patients |
Q72791688 | Treatment and prevention of hyperkalemia in end-stage renal disease |
Q55260411 | Treatment of Hyperkalemia With a Low-Dose Insulin Protocol Is Effective and Results in Reduced Hypoglycemia. |
Q49395610 | Treatment of Severe Hyperkalemia: Confronting 4 Fallacies |
Q41853515 | Treatment of hyperkalaemia using intravenous and nebulised salbutamol |
Q35626591 | Treatment of hyperkalaemia with intravenous salbutamol |
Q71984541 | Treatment of hyperkalemia in children with intravenous salbutamol |
Search more.